Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Niclosamide

SKU: orb1224897

Description

Niclosamide(BAY2353) is used for the treatment of most tapeworm infections by inhibiting DNA replication.

Research Area

Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number50-65-7
MW327.12
Purity>98% (HPLC)
FormulaC13H8Cl2N2O4
SMILESO=C(NC1=CC=C([N+]([O-])=O)C=C1Cl)C2=CC(Cl)=CC=C2O
TargetSTAT
SolubilityEthanol: <1 mg/mL (<1 mM); Water: <1 mg/mL (<1 mM); DMSO: <1 mg/mL (<1 mM)

Bioactivity

In Vivo
Animal model: Nu+/Nu+ mice injected with NCI-H295R cells. Dosage: 100 mg/kg, 200 mg/kg. Administration: Oral gavage; 100 mg/kg, 200 mg/kg; once a week; 8 weeks. Result: Showed a 60%-80% inhibition in tumor growth, as compared to the control group.
In Vitro
Cell Viability Assay Cell line: BD140A, SW-13 and NCI-H295R cells. Concentration: 0.6 nM-46 μM Incubation time: Result: Inhibited cellular proliferation in adrenocortical carcinoma cell lines with the IC50 of 0.12 μM, 0.15 μM, and 0.53 μM in BD140A, SW-13, and NCI-H295R, respectively. Cell Viability Assay Cell line: Hela cells. Concentration: 0.05-5 μM Incubation time: 24 hours. Result: Inhibited STAT3-mediated luciferase reporter activity with an IC50 of 0.25 μM. Cell Viability Assay Cell line: Vero E6 cells. Concentration: 10 μM. Incubation time: 2 days. Result: Inhibited the synthesis of viral antigens of SARS-CoV in Vero E6 cells.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

NSC 178296

Similar Products

  • Niclosamide . ethanolamine [orb1227525]

    greater than or equal to 98%

    1420-04-8

    327.1 . 61.1

    C13H8Cl2N2O4 . C2H7NO

    100 mg
  • Niclosamide monohydrate [orb1704297]

    73360-56-2

    345.14

    C13H10Cl2N2O5

    50 mg, 100 mg, 25 mg
  • SARS-CoV-2-IN-13 [orb1689114]

    98.54% (May vary between batches)

    56961-10-5

    327.12

    C13H8Cl2N2O4

    100 mg, 200 mg, 1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 1 ml x 10 mM (in DMSO)
  • SARS-CoV-2-IN-15 [orb1689213]

    1580-42-3

    315.67

    C14H9ClF3NO2

    50 mg, 100 mg, 25 mg
  • SARS-CoV-2-IN-14 [orb1689487]

    99.78% (May vary between batches)

    22203-98-1

    282.12

    C13H9Cl2NO2

    25 mg, 50 mg, 10 mg, 200 mg, 100 mg, 1 ml x 10 mM (in DMSO)
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Protocol Information